Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|4|486-495

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.4, 2014-02, pp. : 486-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

By Nurmohamed M.T.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1599-1609

Adis International

Access to resources Recommend Favorite

Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 500-512

Bentham Science Publishers

Access to resources Recommend Favorite

Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

By Díaz-Borjón Alejandro  

Drugs & Aging, Vol. 26, Iss. 4, 2009-05 ,pp. : 273-293

Adis International

Access to resources Recommend Favorite

Strategies for the Prevention and Treatment of Osteoporosis in Patients with Rheumatoid Arthritis

By Phillips Kristine   Aliprantis Antonios   Coblyn Jonathan  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 773-779

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite